Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...

Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...

Henry Schein has finally disclosed a data breach following at least two back-to-back cyberattacks in 2023 by the BlackCat Ransomware gang, revealing that over 160,000 people had their personal ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein (HSIC). “We believe we continued to steadily gain market share in our dental and medical distribution businesses following ...

Analysts' ratings for Henry Schein (NASDAQ:HSIC) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below summarizes their recent ratings, showcasing the ...